The pathogenesis of tuberculous meningitis

AG Davis, UK Rohlwink, A Proust… - Journal of leukocyte …, 2019 - academic.oup.com
Tuberculosis (TB) remains a leading cause of death globally. Dissemination of TB to the
brain results in the most severe form of extrapulmonary TB, tuberculous meningitis (TBM) …

Recent advances in understanding the human host immune response in tuberculous meningitis

JR Barnacle, AG Davis, RJ Wilkinson - Frontiers in Immunology, 2024 - frontiersin.org
Tuberculous meningitis (TBM), the most severe form of tuberculosis, causes death in
approximately 25% cases despite antibiotic therapy, and half of survivors are left with …

[HTML][HTML] Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis

EW Tucker, CA Ruiz-Bedoya, F Mota, C Erice… - International journal of …, 2024 - Elsevier
Tuberculous meningitis (TB meningitis) is the most devastating form of tuberculosis (TB) and
there is a critical need to optimize treatment. Linezolid is approved for multidrug resistant TB …

Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis

N Abdelgawad, S Wasserman… - The Journal of …, 2024 - academic.oup.com
Background Linezolid is evaluated in novel treatment regimens for tuberculous meningitis
(TBM). Linezolid pharmacokinetics have not been characterized in this population …

Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial

A Sahib, R Bhatia, MVP Srivastava, MB Singh… - Tuberculosis, 2023 - Elsevier
Most drugs used in the treatment of Tuberculous Meningitis have limited CNS penetration
thereby limiting efficacy. CSF penetration of linezolid is 80–100%. The study was a …

Current Insights into Diagnosing and Treating Neurotuberculosis in Adults

S Dian, AR Ganiem, LH Te Brake, A van Laarhoven - CNS drugs, 2023 - Springer
Neurotuberculosis has the highest morbidity and mortality risk of all forms of extrapulmonary
tuberculosis (TB). Early treatment is paramount, but establishing diagnosis are challenging …

A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease

F Lanni, R Antilus Sainte, M Hansen Jr… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Tuberculosis meningitis (TBM) is essentially treated with the first-line regimen used against
pulmonary tuberculosis, with a prolonged continuation phase. However, clinical outcomes …

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs …

L Arias, K Otwombe, Z Waja, N Tukvadze, T Korinteli… - Trials, 2023 - Springer
Background The duration and regimen of tuberculosis (TB) treatment is currently based
predominantly on whether the M. tuberculosis (Mtb) strain is drug-sensitive (DS) or multidrug …

Treatment of tuberculous meningitis: overdue for concerted action

RJ Wilkinson, J Donovan… - Tuberculosis …, 2023 - pubmed.ncbi.nlm.nih.gov
Treatment of tuberculous meningitis: Overdue for concerted action Treatment of tuberculous
meningitis: Overdue for concerted action Tuberculosis (Edinb). 2023 Sep;142:102361. doi …

Validation of a quantitative liquid chromatography tandem mass spectrometry assay for linezolid in cerebrospinal fluid and its application to patients with HIV …

M Mazanhanga, A Joubert, S Castel, M Van de Merwe… - Heliyon, 2023 - cell.com
Tuberculous meningitis treatment outcomes are poor and alternative regimens are under
investigation. Reliable methods to measure drug concentrations in cerebrospinal fluid are …